Tanya G.K. Bentley ¹, Walter C. Willett ², Milton C. Weinstein ², Karen M. Kuntz ^2*

¹ Harvard University
² Harvard School of Public Health

^* To whom correspondence should be addressed. E-mail: kmk{at}hsph.harvard.edu.

	Abstract

Objectives. We sought to quantify the impact of the 1998 US Food and Drug Administration (FDA) folic acid fortification policy by estimating folate intake at the population level. Methods. We analyzed total folate intake levels (from food and supplements) according to gender, age, and race/ethnicity, using data from 2 National Health and Nutrition Examination Surveys. We measured pre- and postfortification folate intake distributions, adjusted for measurement error, and examined proportions of the population who reached certain thresholds of daily total folate intake. Results. Mean daily food and total folate intake increased by approximately 100 µg/day after fortification. The proportion of women aged 15-44 years who consume more than 400 µg/day of folate has increased since fortification, but has not yet reached the FDA's 50% target, and varies by race/ethnicity from 23% to 33%. Among persons aged 65 years and older who may be at risk for masking a vitamin B12 deficiency, the percentage who consume more than 1000 µg/day (the "tolerable upper intake level") has at least doubled among Whites and Black men, but has remained less than 5% for all groups. Conclusions. Since fortification, folic acid intake among the US population has increased, and there are substantial variations by age, gender, and race/ethnicity.

Key Words: Health Policy, Maternal and Infant Health, Nutrition/Food, Race/Ethnicity, Surveys

This article has been cited by other articles:

				U.S. Preventive Services Task Force Folic Acid for the Prevention of Neural Tube Defects: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, May 5, 2009; 150(9): 626 - 631. [Abstract] [Full Text] [PDF]

				T. Wolff, C. T. Witkop, T. Miller, and S. B. Syed Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, May 5, 2009; 150(9): 632 - 639. [Abstract] [Full Text] [PDF]

				J. Robitaille, H. C Hamner, M. E Cogswell, and Q. Yang Does the MTHFR 677C->T variant affect the Recommended Dietary Allowance for folate in the US population? Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1269 - 1273. [Abstract] [Full Text] [PDF]

				B. S. Mosley, M. A. Cleves, A. M. Siega-Riz, G. M. Shaw, M. A. Canfield, D. K. Waller, M. M. Werler, C. A. Hobbs, and for the National Birth Defects Prevention Study Neural Tube Defects and Maternal Folate Intake Among Pregnancies Conceived After Folic Acid Fortification in the United States Am. J. Epidemiol., January 1, 2009; 169(1): 9 - 17. [Abstract] [Full Text] [PDF]

				L. L. Humphrey, R. Fu, K. Rogers, M. Freeman, and M. Helfand Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis Mayo Clin. Proc., November 1, 2008; 83(11): 1203 - 1212. [Abstract] [Full Text] [PDF]

				J. B. Dowd and A. E Aiello Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int. J. Epidemiol., October 1, 2008; 37(5): 1059 - 1066. [Abstract] [Full Text] [PDF]

				L. N Borrell Commentary: Health policies in the US: can they increase or decrease the gap between subgroups of the population? The case of folic acid Int. J. Epidemiol., October 1, 2008; 37(5): 1067 - 1068. [Full Text] [PDF]

				R. M. Winkels, I. A. Brouwer, P. Verhoef, F. V. A. van Oort, J. Durga, and M. B. Katan Gender and Body Size Affect the Response of Erythrocyte Folate to Folic Acid Treatment J. Nutr., August 1, 2008; 138(8): 1456 - 1461. [Abstract] [Full Text] [PDF]